GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jia Jie Biomedical Co 4109.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

10.20

+0.99%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Jia Jie Biomedical Co

Its shares trade on Taipei Exchange under the ticker 4109.TWO. It has been listed since 2 January 2002. In the fiscal year to 31 December 2025, it reported revenue of TWD 485.4m and net income of TWD 50.3m. At that date it held total assets of TWD 1.89bn and shareholders' equity of TWD 1.68bn.

Jia Jie Biomedical Co., Ltd. engages in the processing, selling, and trading of softshell turtle food. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2002-01-02. The firm operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
2 Jan 2002

Leadership

Pay as last reported

  • Chongjun WengChairman of the Board, since 2024
  • Ms. Wen-Fang HsiehChief Executive Officer, Director, since 2020
  • Wenzhong WuChief Operating Officer
  • Mingjuan ZengGeneral Manager
  • Mr. Qinghong LinDeputy General Manager-Finance Division, Corporate Governance Officer, since 2013
  • Mr. Zhenyi JiangDeputy General Manager
  • Ms. Yiqian ZhongDeputy General Manager
  • Ms. Shujuan CaiDirector
  • Junyi HuangDirector
  • Mr. Gengxian WuDirector
  • Jinkun XieDirector
  • Mr. Weiting XieDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Taiwan Operation segment produces health foods for domestic market demand.
  • China Mainland Operation segment manufactures water purification equipment and parts.
  • Nutrition and health care series products meet growing consumer health trends.

Weaknesses

  • Limited product range compared to competitors in Consumer Staples sector.
  • Dependence on Taiwan and mainland China for sales markets.
  • No international expansion mentioned in business description.

Opportunities

  • Growing demand for health foods in Taiwan's Consumer Staples market.
  • Potential for expanding water purification equipment sales in China Mainland.
  • Increasing consumer interest in health water series products.

Threats

  • Competition from established health food brands in Taiwan.
  • Regulatory changes affecting water purification equipment in China.
  • Economic slowdown impacting consumer spending on health products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.